Cardiologists at The Ohio State University Wexner Medical Center are the first in the United States to test a new type of ablation technology for patients suffering from atrial fibrillation, a common type of irregular heartbeat.

The team is participating in a global clinical trial to assess pulsed field ablation (PFA) technology to treat patients with atrial fibrillation. Developed by.